Skip to main content

buprenorphine Archives

New model helps expand opioid use care options

Feb. 3, 2022—Vanderbilt is using an innovative hub and spoke treatment model to care for patients with opioid use disorder.

Read more


Opioid use disorder treatment access increases in areas with large Medicaid population

Jan. 4, 2022—  by Jill Clendening Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining...

Read more


Multisite study focuses on opioid use during pregnancy

Dec. 5, 2019—The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more